Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 2
2004 4
2005 1
2006 4
2007 2
2008 2
2009 2
2010 4
2011 3
2012 2
2013 8
2014 5
2015 9
2016 9
2017 6
2018 5
2019 6
2020 15
2021 16
2022 15
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees.
Tokumaru T, Toyama T, Nakade Y, Ogura H, Oshima M, Nakagawa S, Furuichi M, Kitajima S, Sakai N, Shimizu M, Iwata Y, Wada T. Tokumaru T, et al. Among authors: sakai n. Clin Exp Nephrol. 2024 May;28(5):440-446. doi: 10.1007/s10157-023-02450-x. Epub 2024 Feb 10. Clin Exp Nephrol. 2024. PMID: 38340247 Free PMC article. Clinical Trial.
Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting.
Shimada T, Kawakami D, Fujita A, Yamamoto R, Hara S, Ito K, Mizushima I, Kitajima S, Iwata Y, Sakai N, Kawano M, Wada T, Sai Y. Shimada T, et al. Among authors: sakai n. J Pharm Health Care Sci. 2024 Jan 8;10(1):5. doi: 10.1186/s40780-023-00318-6. J Pharm Health Care Sci. 2024. PMID: 38191469 Free PMC article.
Protective Role of MAVS Signaling for Murine Lipopolysaccharide-Induced Acute Kidney Injury.
Tran TAT, Iwata Y, Hoang LT, Kitajima S, Yoneda-Nakagawa S, Oshima M, Sakai N, Toyama T, Yamamura Y, Yamazaki H, Hara A, Shimizu M, Sako K, Minami T, Yuasa T, Horikoshi K, Hayashi D, Kajikawa S, Wada T. Tran TAT, et al. Among authors: sakai n. Immunohorizons. 2024 Jan 1;8(1):1-18. doi: 10.4049/immunohorizons.2300069. Immunohorizons. 2024. PMID: 38169549 Free PMC article.
Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study.
Oshima M, Toyama T, Nakade Y, Yomogida D, Yuasa T, Horikoshi K, Minami T, Ogura H, Nakagawa S, Miyagawa T, Kitajima S, Hara A, Sakai N, Shimizu M, Mita M, Kinoshita M, Nakada M, Kikuchi M, Iwata Y, Wada T. Oshima M, et al. Among authors: sakai n. Clin Ther. 2023 Sep;45(9):889-893. doi: 10.1016/j.clinthera.2023.07.002. Epub 2023 Jul 22. Clin Ther. 2023. PMID: 37487866
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
Shimizu M, Furuichi K, Toyama T, Yamanouchi M, Hoshino J, Kitajima S, Hara A, Iwata Y, Sakai N, Yuzawa Y, Kitamura H, Sato H, Shibagaki Y, Suzuki Y, Uesugi N, Ueda Y, Kohagura K, Samejima K, Tsuruya K, Nishi S, Nishino T, Makino H, Matsuo S, Ubara Y, Yokoyama H, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development. Shimizu M, et al. Among authors: sakai n. J Diabetes Investig. 2023 Nov;14(11):1268-1278. doi: 10.1111/jdi.14059. Epub 2023 Jul 22. J Diabetes Investig. 2023. PMID: 37483063 Free PMC article.
Myocardin-related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts.
Yamamura Y, Sakai N, Iwata Y, Lagares D, Hara A, Kitajima S, Toyama T, Miyagawa T, Ogura H, Sato K, Oshima M, Nakagawa S, Tamai A, Horikoshi K, Matsuno T, Yamamoto N, Hayashi D, Toyota Y, Kaikoi D, Shimizu M, Tager AM, Wada T. Yamamura Y, et al. Among authors: sakai n. FASEB J. 2023 Jul;37(7):e23005. doi: 10.1096/fj.202201870R. FASEB J. 2023. PMID: 37289107
Intra-Brain and Plasma Levels of L-Serine Are Associated with Cognitive Status in Patients with Chronic Kidney Disease.
Iwata Y, Nakade Y, Kinoshita M, Sabit H, Nakajima R, Furuichi K, Mita M, Nakane M, Sakai N, Kitajima S, Toyama T, Miyagawa T, Hara A, Shimizu M, Sato K, Oshima M, Nakagawa S, Yamamura Y, Ogura H, Koshino Y, Nakada M, Wada T. Iwata Y, et al. Among authors: sakai n. Kidney Dis (Basel). 2023 Jan 13;9(2):118-129. doi: 10.1159/000527798. eCollection 2023 Apr. Kidney Dis (Basel). 2023. PMID: 37065608 Free PMC article.
Initiation of renin-angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study.
Shimizu S, Niihata K, Nishiwaki H, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N; Japan Nephrotic Syndrome Cohort Study Group. Shimizu S, et al. Clin Exp Nephrol. 2023 May;27(5):480-489. doi: 10.1007/s10157-023-02331-3. Epub 2023 Feb 25. Clin Exp Nephrol. 2023. PMID: 36840902
Sex differences in risk factors for end-stage kidney disease and death in type 2 diabetes: A retrospective cohort study.
Oshima M, Iwata Y, Toyama T, Kitajima S, Hara A, Sakai N, Shimizu M, Furuichi K, Haneda M, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Makino H, Wada T. Oshima M, et al. Among authors: sakai n. J Diabetes. 2023 Mar;15(3):246-254. doi: 10.1111/1753-0407.13367. Epub 2023 Feb 13. J Diabetes. 2023. PMID: 36785912 Free PMC article.
114 results